• Human TET2 protein (Recombinant) (Please contact us for more information.) (STJP001330)
  • Human TET2 protein (Recombinant) (Please contact us for more information.) (STJP001330)
  • Human TET2 protein (Recombinant) (Please contact us for more information.) (STJP001330)
  • Human TET2 protein (Recombinant) (Please contact us for more information.) (STJP001330)

Human TET2 protein (Recombinant) (Please contact us for more information.) (STJP001330)

SKU:
STJP001330

Current Stock:
Host: HEK293 cells
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human TET2-Please contact us for more information. protein was developed from hek293 cells and has a target region of Please contact us for more information.. For use in research applications.
Formulation: Supplied as a 0.22 Mu m filtered solution of 50mM HEPES, 300mM NaCl, 1mM TCEP, 10% Glycerol, pH 8.0.
Endotoxin: Please contact us for more information.
Immunoreactivity: Measured by its binding ability in a functional ELISA. Immobilized Human TET2 Protein at 1 Mu g/mL (100 Mu L/well) can bind TET2 Rabbit pAb with a linear range of 0.976-232.5 ng/mL.
Gene Symbol: TET2
Gene ID: 54790
Uniprot ID: TET2_HUMAN
Immunogen Region: Asp1129-Ser1480
Immunogen: Recombinant Human TET2 Protein is produced by HEK293 cells expression system.
Tissue Specificity Broadly expressed. Highly expressed in hematopoietic cells.highest expression observed in granulocytes. Expression is reduced in granulocytes from peripheral blood of patients affected by myelodysplastic syndromes.
Post Translational Modifications May be glycosylated. It is unclear whether interaction with OGT leads to GlcNAcylation. According to a report, it is not GlcNAcylated by OGT. In contrast, another group reports GlcNAcylation by OGT in mouse ortholog. Monoubiquitinated at Lys-1299 by the DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex called CRL4(VprBP) or CUL4A-RBX1-DDB1-DCAF1/VPRBP complex.this modification promotes binding to DNA.
Function Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Has a preference for 5-hydroxymethylcytosine in CpG motifs. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, also involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.
Protein Name Methylcytosine Dioxygenase Tet2
Database Links Reactome: R-HSA-5221030
Reactome: R-HSA-9827857
Cellular Localisation Nucleus
Chromosome
Localization To Chromatin Depends Upon Monoubiquitination At Lys-1299
Alternative Protein Names Methylcytosine Dioxygenase Tet2 protein
TET2 protein
KIAA1546 protein
Nbla00191 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance